Sponsor or institution
Clinical trials and research at Armida Labs, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $2.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Targeting pancreatic and other cancers with Targefrin to slow metastasis
A new therapy called Targefrin-dimer aims to shut down the EphA2 receptor that helps cancer spread, with tests planned in pancreatic and other solid tumors.
-
Targefrin treatment to stop pancreatic cancer from spreading
This project is developing Targefrin, a drug that targets the EphA2 protein to help stop pancreatic cancer cells from spreading and move the drug toward testing in people.
-
Targeting a specific receptor to fight pancreatic cancer spread
This study is testing a new treatment for metastatic pancreatic cancer that targets a specific protein on cancer cells to help stop their spread and deliver chemotherapy directly to the tumors, aiming to improve outcomes for patients like you.
-
Targeting a specific receptor to fight pancreatic cancer spread
This study is testing a new treatment for metastatic pancreatic cancer that targets a specific protein on cancer cells to help stop their spread and improve chemotherapy, and it’s looking for patients who want to try this promising approach.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.